Authors: Borş Silviu-Ionuț, Dascălu Dan-Lucian, Borş Alina, Fahmy Hossam M, Kandil Omaima M, Abdoon Ahmed Sabry S
Journal: Animals : an open access journal from MDPI
Summary
# Editorial Summary Researchers investigating novel approaches to enhance reproductive efficiency in cattle trialled intraovarian injections of a lyophilised growth factor derived from equine blood platelets (L-GFequina) across three treatment protocols in Holstein cows, comparing outcomes against standard ovum pick-up and in vitro embryo production (OPU-IVEP) procedures. The study involved 12 cows subjected to different stimulation regimens: a control protocol with two OPU sessions, a treatment group receiving L-GFequina injection plus equine chorionic gonadotropin (eCG) with three OPU sessions, and a second control group receiving eCG alone with two OPU sessions. Intraovarian L-GFequina injection significantly improved key reproductive markers, increasing the number of cumulus–oocyte complexes (COCs) recovered per cycle and enhancing blastocyst production compared to both control groups (p < 0.05). For practitioners engaged in assisted reproductive technologies or breeding programmes, these findings suggest that growth factor therapy may offer a practical means of improving oocyte yield and embryo viability without substantially altering established OPU protocols—though the transferability of equine-derived factors to bovine reproductive physiology warrants further investigation into optimal dosing and application timing.
Read the full abstract on PubMed
Practical Takeaways
- •This research is not applicable to equine practice; it studies cattle reproduction using an equine-derived growth factor
- •While the study uses horse blood platelet extract, the findings are limited to in vitro embryo production in dairy cattle and do not translate to equine clinical practice
- •The study demonstrates potential applications of equine biological products in other species but offers no direct clinical guidance for equine practitioners
Key Findings
- •Intraovarian injection of L-GFequina significantly increased the number of OPU sessions per cycle (p < 0.05)
- •L-GFequina treatment significantly improved recovery of cumulus-oocyte complexes (COCs) compared to control
- •L-GFequina-treated group produced significantly more blastocysts than control group
- •Combined L-GFequina and eCG protocol with 3 OPU sessions (days 6, 10, 14) outperformed protocols with fewer interventions